15min chapter

Psychedelics Today cover image

PT572 – The Potential of Buprenorphine, the Risks of Ketamine, and How Psychedelics Could Prevent Nuclear War, with Howard Kornfeld, MD

Psychedelics Today

CHAPTER

Buprenorphine and MDMA: Therapeutic Potential and Approval Challenges

This chapter explores the properties of buprenorphine as a long-acting opioid that effectively alleviates withdrawal symptoms with reduced addiction risks. It contrasts this with the challenges faced by MDMA in therapeutic settings, particularly concerning its regulatory approval and biases in research. The discussion emphasizes the discrepancies between subjective participant experiences and regulatory expectations, advocating for a more nuanced understanding of these substances' therapeutic potentials.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode